Chromatin states define tumour-specific T cell dysfunction and reprogramming-Reference-Cited by-同舟云学术

Chromatin states define tumour-specific T cell dysfunction and reprogramming

Published:2017-05 Issue:7655 Volume:545 Page:452-456
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Philip Mary,Fairchild Lauren,Sun Liping,Horste Ellen L.,Camara Steven,Shakiba Mojdeh,Scott Andrew C.,Viale Agnes,Lauer Peter,Merghoub Taha,Hellmann Matthew D.,Wolchok Jedd D.,Leslie Christina S.,Schietinger Andrea

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature22367.pdf

Reference50 articles.

1. Hellström, I., Hellström, K. E., Pierce, G. E. & Yang, J. P. Cellular and humoral immunity to different types of human neoplasms. Nature 220, 1352–1354 (1968)

2. Khalil, D. N., Smith, E. L., Brentjens, R. J. & Wolchok, J. D. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nat. Rev. Clin. Oncol. 13, 273–290 (2016)

3. Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371, 2189–2199 (2014)

4. Kelderman, S., Schumacher, T. N. & Haanen, J. B. Acquired and intrinsic resistance in cancer immunotherapy. Mol. Oncol. 8, 1132–1139 (2014)

5. Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124–128 (2015)

Cited by 692 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to immunotherapy;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Roles of the tumor microenvironment in the resistance to programmed cell death protein 1 inhibitors in patients with gastric cancer;World Journal of Gastrointestinal Oncology;2024-09-15

3. Autoregulated splicing of TRA2 β programs T cell fate in response to antigen-receptor stimulation;Science;2024-09-13

4. CD4 ⁺ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy;Science Immunology;2024-09-13

5. Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation;Scientific Reports;2024-09-12